Trial intelligence / Profile preview

Effects of L-arginine in prophylaxis of chronic hypertension from the second trimester of pregnancy

2005-000194-21Phase 2Completed

Sponsor
AOU Policlinico di Modena
Start
Sep 2007
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in hypertension (HTN) and pregnancy-induced hypertension (PIH) comparing L-arginine with Placebo (2 arms). Primary endpoints: Change in arterial blood pressure and Need for antihypertensive therapy. Started Sep 2007; status: completed.

02

Drugs

arginine
03

Conditions

hypertension (HTN)pregnancy-induced hypertension (PIH)

Beyond the preview

Go deeper on 2005-000194-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000194-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call